Why Blue Star’s Share Price Is Falling Despite Stable Results ?

Blue Star, one of India’s leading air conditioning and commercial refrigeration companies, released its financial update for the quarter and half year ended September 30, 2025. While the company reported some growth in revenue and profit, the underlying data shows a slowdown in key consumer segments, rising debt, and muted order inflows, explaining why investors have turned cautious and the stock has come under pressure.

Weak Demand in the Room AC Segment

• The Room Air Conditioner segment remained weak after a subdued monsoon-led Q1FY26, as prolonged rains and cooler temperatures hurt demand.
• This led to lower secondary sales and delayed channel offtake, as distributors hesitated to place new orders.
• The Unitary Products division (which includes room ACs and appliances) saw revenue fall 9.5% year-on-year to ₹693.81 crore, and margins drop to 6.2% from 7.0%.
• A GST rate cut announced on August 15, 2025 and effective September 22, 2025 caused buyers to postpone purchases until lower post-GST prices kicked in.
• Together, unfavourable weather and GST-related deferment sharply slowed consumer demand, making it the key reason behind Blue Star’s weak Q2 showing in its consumer business.

Segment-Wise Pressure and Margin Dip

The slowdown was most visible in the Unitary Products segment, which saw a 9.5% decline in revenue and a margin dip from 7.0% to 6.2%. The company’s Commercial Refrigeration business also had a modest quarter, though management expects better demand in the second half of FY26 after the GST reduction on food products.

Meanwhile, the Professional Electronics and Industrial Systems segment de-grew 20.1% year-on-year to ₹64.35 crore (from ₹80.54 crore), largely due to uncertainties in its MedTech business, which is awaiting clarity on new regulatory frameworks. Despite lower revenue, cost-cutting helped this segment maintain a higher margin of 9.6%, compared to 6.4% last year.

Financial Snapshot: What the Numbers Say

Despite operational headwinds, Blue Star managed to report modest top-line growth. Key figures from Q2 FY26 are as follows:

• Revenue from operations: ₹2,422.37 crore, up 6.4% year-on-year (₹2,275.96 crore in Q2FY25)
• EBITDA: ₹183.41 crore versus ₹149.31 crore last year; EBITDA margin improved to 7.6% from 6.6%
• Profit before tax: ₹133.16 crore, up just 1.3% from ₹131.39 crore last year
• Net profit: ₹98.78 crore, up 2.8% year-on-year (₹96.06 crore in Q2FY25)
• Net borrowings: ₹417.06 crore as of September 30, 2025, compared to a net cash position of ₹185.26 crore a year ago

While revenues grew slightly and margins improved, profit growth remained muted and debt levels surged. This shift from net cash to net debt has made investors wary about rising interest costs and tighter cash flows.

Slower Order Inflows in Project Business

The Electro-Mechanical Projects and Commercial Air Conditioning segment, which caters to large infrastructure projects, factories, and data centers, showed stronger billing and revenue growth, rising 16.5% to ₹1,664.21 crore compared to ₹1,428.42 crore in Q2FY25. However, new order inflows were flat at ₹1,921.93 crore versus ₹1,899.99 crore in the same quarter last year.

The carried-forward order book for this division fell 3.9% year-on-year to ₹4,840.46 crore, reflecting a slowdown in fresh project finalizations despite healthy enquiries. This decline signals that while current execution remains stable, future revenue visibility could weaken if new orders don’t pick up soon.

Rising Borrowings and Capital Costs

One of the most noticeable shifts in Blue Star’s balance sheet is the jump in debt. The company’s net borrowings rose to ₹417.06 crore as of September 2025, compared to a net cash balance of ₹185.26 crore a year ago. Meanwhile, capital employed increased to ₹3,530.88 crore from ₹2,550.28 crore in September 2024.

This rise in leverage indicates that the company is funding higher working capital or expansion needs, but it also raises financing costs. When combined with modest growth, this trend is likely adding to investor caution.

External and Regulatory Challenges

Blue Star’s international business saw some progress with supplies ramping up in the US market during Q1 and Q2 FY26. However, tariff-related uncertainties and delays in concluding an India-US trade deal continue to create a drag.

Additionally, the MedTech Solutions business has been affected by delays in the finalization of a new regulatory policy framework. These external issues, though temporary, have limited the company’s ability to capture new growth opportunities abroad and in healthcare-related solutions.

Market Reaction and Outlook

Even with a revenue increase of 6.4% and margin improvement, the overall tone of the results is subdued. Sluggish consumer demand, slower order inflows, margin pressure, and higher debt levels are dampening investor confidence.

Blue Star’s management remains optimistic that the GST rate cut will revive demand in the next quarter and that ongoing cost and working capital initiatives will improve second-half performance. However, until stronger sales momentum and project orders return, the market is likely to remain cautious about the stock.

In essence, Blue Star’s falling share price reflects short-term headwinds rather than a long-term weakness. The company’s fundamentals remain sound, but with muted growth and rising debt, investors are waiting to see signs of a clearer recovery before re-rating the stock.

Disclaimer

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. The securities are quoted as an example and not as a recommendation.This is nowhere to be considered as an advice, recommendation or solicitation of offer to buy or sell or subscribe for securities. INDStocks SIP / Mini Save is a SIP feature that enables Customer(s) to save a fixed amount on a daily basis to invest in Indian Stock. INDstocks Private Limited (formerly known as INDmoney Private Limited) 616, Level 6, Suncity Success Tower, Sector 65, Gurugram, 122005, SEBI Stock Broking Registration No: INZ000305337, Trading and Clearing Member of NSE (90267, M70042) and BSE, BSE StarMF (6779), SEBI Depository Participant Reg. No. IN-DP-690-2022, Depository Participant ID: CDSL 12095500, Research Analyst Registration No. INH000018948 BSE RA Enlistment No. 6428. Refer https://indstocks.com/pricing?type=indian-stocks; https://www.indstocks.com/page/indian-stocks-sip-terms-and-condition for further details.